| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Gilead Sciences is demonstrating significant progress in product and service development, primarily through its strong focus on advancements in antiviral research and the successful outcomes of its clinical trials. The positive clinical trial results, particularly for Trodelvy, underscore the company's commitment to delivering innovative treatment options that address crucial health challenges. Such achievements not only enhance patient outcomes but also solidify Gilead's reputation as a leader in the pharmaceutical field. However, the competitive landscape and regulatory hurdles in drug development remain persistent challenges for the company. |
| The price action of Gilead Sciences (GILD) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.2 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for GILD since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0, and the negative at -0.2 on 2025-10-22. The forces of Valuation Sentiment (-1), and Sentiment towards Fundamentals (-0.2) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), and Market Risk Appetite (0) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| GILD | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-22 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-10-21 | 0%(0%) | 0 | 0% | 0.1 | 1.7 | -1 | |||||||
| 2025-10-20 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-10-19 | 0%(0%) | 0 | 0% | 0.5 | 4 | -1 | |||||||
| 2025-10-18 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2025-10-17 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | 7 | |||||||
| 2025-10-16 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | -1 | |||||||
| 2025-10-15 | 0%(0%) | 0 | 0% | 0.5 | 4 | -1 | |||||||
| 2025-10-14 | 0%(0%) | 0 | 0% | 0.5 | 3.8 | -1 | |||||||
| 2025-10-13 | 0%(0%) | 0 | 0% | 0.5 | 3.8 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-22 17:11:25 Analysts might express caution regarding Gilead's future based on recent stock performance trends. |
| 2025-10-22 17:11:25 Investors may be worrying about the cost structure and financial health of Gilead Sciences following the stock decline. |
| 2025-10-22 17:11:25 The stock drop may be indicative of increased competition within the industry affecting Gilead's market standing. |
| 2025-10-22 17:11:25 The decline in stock price can reflect a negative perception of the company's overall earnings potential. |
| 2025-10-22 17:11:25 The negative performance of Gilead Sciences stock indicates current investor concerns and market volatility. |